CNS Pharmaceuticals, Inc. (CNSP)
2.311
+0.04
(+1.81%)
USD |
NASDAQ |
May 01, 16:00
2.34
+0.03
(+1.25%)
After-Hours: 20:00
CNS Pharmaceuticals EPS Diluted (Quarterly) : -10.15 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.292 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.956M |
| Total Expenses (Quarterly) | 5.956M |
| Enterprise Value | -4.997M |
| Earnings Yield | -1.03K% |
| Normalized Earnings Yield | -1034.38 |